Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Klus Pharma Inc.
Klus Pharma Inc.
Quadriga Biosciences, Inc.
Wake Forest University Health Sciences
Fox Chase Cancer Center
National Cancer Institute (NCI)